ADIM
OCSL icon

Alpha DNA Investment Management’s Oaktree Specialty Lending OCSL Stock Holding History

Alpha DNA Investment Management’s Portfolio OCSL Stock Details OCSL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-57,375
Closed -$1.08M – 204
2023
Q1 		$1.08M Buy
+57,375
New +$1.14M 0.32% 86
2022
Q3 		– Sell
-53,739
Closed -$1.05M – 186
2022
Q2 		$1.05M Buy
+53,739
New +$1.13M 0.9% 37

Other funds holding OCSL

OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return

Alpha DNA Investment Management's OCSL Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Oaktree Specialty Lending (OCSL) in Q2 2023, closing a stake of 57,375 shares — an estimated $1.08M sold.

Alpha DNA Investment Management first reported a position in OCSL in Q2 2022 and held it in 2 quarters. The position peaked at $1.08M in Q1 2023. 182 funds tracked by Wall St. Rank hold OCSL as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Oaktree Specialty Lending position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 57,375 Oaktree Specialty Lending shares in Q2 2023, an estimated $1.08M.
  • Alpha DNA Investment Management first reported a position in Oaktree Specialty Lending in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Oaktree Specialty Lending position peaked at $1.08M in Q1 2023.
  • 182 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.